These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 34474706)

  • 1. How important is proper dosing for subcutaneous and sublingual allergy immunotherapy?
    Nelson HS
    Allergy Asthma Proc; 2021 Sep; 42(5):368-377. PubMed ID: 34474706
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of standardized extracts in allergen immunotherapy.
    Nelson HS
    J Allergy Clin Immunol; 2000 Jul; 106(1 Pt 1):41-5. PubMed ID: 10887303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dosing of European sublingual immunotherapy maintenance solutions relative to monthly recommended dosing of subcutaneous immunotherapy.
    Larenas-Linnemann DE; Mösges R
    Allergy Asthma Proc; 2016; 37(1):50-6. PubMed ID: 26831847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An evidence-based analysis of house dust mite allergen immunotherapy: a call for more rigorous clinical studies.
    Calderon MA; Casale TB; Nelson HS; Demoly P
    J Allergy Clin Immunol; 2013 Dec; 132(6):1322-36. PubMed ID: 24139829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-response relationship of a new Timothy grass pollen allergoid in comparison with a 6-grass pollen allergoid.
    Pfaar O; Hohlfeld JM; Al-Kadah B; Hauswald B; Homey B; Hunzelmann N; Schliemann S; Velling P; Worm M; Klimek L
    Clin Exp Allergy; 2017 Nov; 47(11):1445-1455. PubMed ID: 28696503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence-based dosing of maintenance subcutaneous immunotherapy: a contemporary review of state-of-the-art practice.
    Hoover H; Leatherman B; Ryan M; McMains K; Veling M
    Int Forum Allergy Rhinol; 2018 Jul; 8(7):806-816. PubMed ID: 29631326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maintenance dosing for sublingual immunotherapy by prominent European allergen manufacturers expressed in bioequivalent allergy units.
    Larenas-Linnemann D; Esch R; Plunkett G; Brown S; Maddox D; Barnes C; Constable D
    Ann Allergy Asthma Immunol; 2011 Nov; 107(5):448-458.e3. PubMed ID: 22018618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Art of Dosing for Subcutaneous Immunotherapy in North America.
    Nelson HS; Sowers T; Plunkett G; Nolte H; Rance K
    J Allergy Clin Immunol Pract; 2024 Jan; 12(1):13-22. PubMed ID: 37385447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapy for house-dust mite allergy.
    Nelson HS
    Allergy Asthma Proc; 2018 Jul; 39(4):264-272. PubMed ID: 30095391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sublingual immunotherapy: the U.S. experience.
    Nelson HS
    Curr Opin Allergy Clin Immunol; 2013 Dec; 13(6):663-8. PubMed ID: 24169432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of sublingual immunotherapy tablets in dust mite and pollen allergy.
    Bisyuk Y; DuBuske I; DuBuske LM
    Allergy Asthma Proc; 2021 Jan; 42(1):36-42. PubMed ID: 33404387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of respiratory allergy with allergy immunotherapy tablets.
    Bachert C
    Allergy; 2011 Jul; 66 Suppl 95():57-9. PubMed ID: 21668858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability of standardized grass, dust mite, cat, and short ragweed allergens after mixing with mold or cockroach extracts.
    Grier TJ; LeFevre DM; Duncan EA; Esch RE
    Ann Allergy Asthma Immunol; 2007 Aug; 99(2):151-60. PubMed ID: 17718103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epinephrine Use in Clinical Trials of Sublingual Immunotherapy Tablets.
    Nolte H; Casale TB; Lockey RF; Fogh BS; Kaur A; Lu S; Nelson HS
    J Allergy Clin Immunol Pract; 2017; 5(1):84-89.e3. PubMed ID: 27838323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral/sublingual Phleum pretense grass tablet (Grazax/Grastek) to treat allergic rhinitis in the USA.
    Nelson HS
    Expert Rev Clin Immunol; 2014 Nov; 10(11):1437-51. PubMed ID: 25340426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tablet-based sublingual immunotherapy for respiratory allergy.
    Prieto L
    Allergol Immunopathol (Madr); 2017 Dec; 45 Suppl 1():30-35. PubMed ID: 29146015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term efficacy of the sublingual and subcutaneous routes in allergen immunotherapy.
    Penagos M; Durham SR
    Allergy Asthma Proc; 2022 Jul; 43(4):292-298. PubMed ID: 35818157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of effect of Timothy grass pollen sublingual immunotherapy tablet on birch pollen-induced allergic rhinoconjunctivitis in an environmental exposure unit.
    Ellis AK; Tenn MW; Steacy LM; Adams DE; Day AG; Walker TJ; Nolte H
    Ann Allergy Asthma Immunol; 2018 May; 120(5):495-503.e2. PubMed ID: 29432967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sublingual immunotherapy for allergic rhinitis.
    Wilson DR; Torres LI; Durham SR
    Cochrane Database Syst Rev; 2003; (2):CD002893. PubMed ID: 12804442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compatibility of imported fire ant whole body extract with cat, ragweed, Dermatophagoides pteronyssinus, and timothy grass allergens.
    Rans TS; Hrabak TM; Whisman BA; Grier TJ; LeFevre DM; Kwon PO; Tankersley MS
    Ann Allergy Asthma Immunol; 2009 Jan; 102(1):57-61. PubMed ID: 19205287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.